Literature DB >> 16326672

Tramadol does not impair the phagocytic capacity of human peripheral blood cells.

Benzion Beilin1, Galina Grinevich, Israel Z Yardeni, Hanna Bessler.   

Abstract

PURPOSE: The inhibitory effect of opioids on phagocytic cell capacity is well established. However, the effect of synthetic analgesics on this aspect of cell function is controversial. It was the aim of the study to compare the in vitro effect of tramadol with that of morphine on the engulfing ability of peripheral blood phagocytic cells from healthy volunteers.
METHODS: Peripheral blood polymorphonuclear cells and monocytes from healthy volunteers were incubated with 5, 10 and 20 microg.mL(-1) tramadol, or with 20, 40 and 80 etag.mL(-1) morphine. To each tube, 0.05 mL of 5% suspension of latex beads 0.8 microm in diameter was added. After incubation for 60 min the percentage of cells engulfing latex particles and the phagocytic index (number of particles phagocytized by each individual cell) were detected.
RESULTS: Tramadol affected neither the percentage of cells phagocyting latex particles, nor the phagocytic index of both polymorphonuclear cells and monocytes. On the other hand, incubation with 20, 40 and 80 etag.mL(-1) morphine caused 11%, 14% and 24% decrease in phagocytosis (P < 0.01 - P < 0.001). The percentage of monocytes phagocyting latex particles was lower by 16%, 19% and 12% at the three doses tested (P < 0.01 - P < 0.001). The three doses of morphine caused a dose dependent decrease in the monocyte phagocyting index by 20%, 29% and 35.5% respectively (P < 0.05). The polymorphonuclear phagocyting index was not significantly lower following incubation with the drug (P = 0.053).
CONCLUSION: The lack of noxious effect of tramadol on the engulfing capacity of phagocytic cells suggests additional benefit to the relatively safe profile of the drug.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326672     DOI: 10.1007/BF03021601

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  6 in total

1.  Tramadol differentially regulates M1 and M2 macrophages from human umbilical cord blood.

Authors:  Jun Zhang; Liang Chen; Yunyun Sun; Yuanhai Li
Journal:  Inflammopharmacology       Date:  2017-03-17       Impact factor: 4.473

Review 2.  New Insights on Tramadol and Immunomodulation.

Authors:  Iqira Saeed; Adam La Caze; Markus W Hollmann; Paul N Shaw; Marie-Odile Parat
Journal:  Curr Oncol Rep       Date:  2021-08-27       Impact factor: 5.075

Review 3.  Do All Opioid Drugs Share the Same Immunomodulatory Properties? A Review From Animal and Human Studies.

Authors:  Silvia Franchi; Giorgia Moschetti; Giada Amodeo; Paola Sacerdote
Journal:  Front Immunol       Date:  2019-12-12       Impact factor: 7.561

Review 4.  Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review.

Authors:  Aleksandra Kotlińska-Lemieszek; Zbigniew Żylicz
Journal:  Drug Des Devel Ther       Date:  2022-01-18       Impact factor: 4.162

5.  Morphine reduces local cytokine expression and neutrophil infiltration after incision.

Authors:  J David Clark; Xiaoyou Shi; Xiangqi Li; Yanli Qiao; DeYong Liang; Martin S Angst; David C Yeomans
Journal:  Mol Pain       Date:  2007-10-02       Impact factor: 3.395

6.  Does tramadol affect coagulation status of patients with malignancy?

Authors:  Ayten Bilir; Meltem Olga Akay; Dilek Ceyhan; Neslihan Andıc
Journal:  Indian J Pharmacol       Date:  2014 Jul-Aug       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.